A5069745472- Heart Failure Treatment and Management
- Transplantation: Methods and Outcomes
- Cardiovascular Function and Risk Factors
- Mechanical Circulatory Support Devices
- Potassium and Related Disorders
- Cardiac Structural Anomalies and Repair
- COVID-19 Clinical Research Studies
- Heart Rate Variability and Autonomic Control
- Pulmonary Hypertension Research and Treatments
- Blood Pressure and Hypertension Studies
- Frailty in Older Adults
- Cardiovascular and exercise physiology
- Cardiac pacing and defibrillation studies
- Cardiac Health and Mental Health
- Electrolyte and hormonal disorders
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiovascular and Diving-Related Complications
- Organ Transplantation Techniques and Outcomes
- Renal function and acid-base balance
- Vascular Anomalies and Treatments
- Pericarditis and Cardiac Tamponade
- SARS-CoV-2 and COVID-19 Research
- Erythropoietin and Anemia Treatment
Hospital Clínic de Barcelona
2023-2025
Universitat de Barcelona
2025
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
2025
Hospital Universitario 12 De Octubre
2019-2024
Centro de Investigación en Red en Enfermedades Cardiovasculares
2019-2024
Hospital Universitari de Vic
2023-2024
Centro de Investigación Biomédica en Red
2020-2024
Research Institute Hospital 12 de Octubre
2020-2021
Universidad Complutense de Madrid
2021
Instituto de Salud Carlos III
2020-2021
Background: High-flow nasal cannula oxygen therapy (HFNC) has been shown to be a useful in the treatment of patients with Acute Respiratory Distress Syndrome (ARDS), but its efficacy is still unknown COVID-19. Our objective describe utility as for ARDS caused by SARS-CoV-2. Methods: A retrospective, observational study was performed at single centre, evaluating secondary COVID-19 treated HFNC. The main outcome intubation rate day 30, which defined failure therapy. We also analysed role ROX...
Background/Objectives: Heart failure (HF) is a leading cause of morbidity and mortality worldwide, with higher prevalence among older adults. Iron deficiency (ID), affecting up to 50% HF patients, closely linked chronic inflammation, exacerbating outcomes. This review aims explore the interplay between ID, HF, focusing on identify therapeutic gaps emerging treatment strategies. Methods: A comprehensive literature was conducted, empha-sizing pathophysiological mechanisms inflammation ID in...
ABSTRACT Donation after circulatory death is helping to expand the donor pool for heart transplantation. Nevertheless, these hearts are more susceptible myocardial edema and decision of accepting organ can be a challenge transplant team. Hemodynamic echocardiographic criteria used routinely, but there still lack strong evidence that supports decision-making in particular situations. That why authors found useful analyze case with good outcome could help organs situation shortage.
Abstract Aims Information about current use of finerenone in patients with heart failure (HF) clinical practice is scarce, and its effectiveness scarce. We aim to assess both the baseline profile prognostic role HF, irrespective ejection fraction. Methods results The study a multicentre, observational registry, including regional tertiary hospitals. registry incorporates contributions from cardiology, internal medicine, nephrology departments, ensuring comprehensive data collection. Patients...
Background Acute coronary syndrome ( ACS ) patients are increasingly older. Conventional prognostic scales include chronological age but do not consider vulnerability. In elderly patients, a frail phenotype represents better reflection of biological age. Hypothesis: This study aims to determine the prevalence frailty and its influence on ≥75 years with ACS. Methods Patients admitted due type 1 myocardial infarction were included in 2 tertiary hospitals, clinical data collected prospectively....
<b><i>Background:</i></b> Myocardial infarction (MI) patients are increasingly older, and common risk scores include chronological age, but do not consider chronic comorbidity or biological age. Frailty status reflects these variables may be independently correlated with prognosis in this setting. <b><i>Objective:</i></b> This study investigated the impact of frailty on elderly admitted due to MI. <b><i>Methods:</i></b>...
Background: Poor natriuresis has been associated with a poorer response to diuretic treatment and worse prognosis in acute heart failure. Recommendations on how when measure urinary sodium (UNa) are lacking. We aim evaluate UNa quantification after furosemide stress test (FST) capacity predict appropriate decongestion during failure hospitalization. Methods: Patients underwent an FST day-1 of admission, was measured 2 hours after, dividing patients into low or high based the sample median...
It is recommended to assess frailty prior heart transplantation (HT). Our objective was the prevalence of in patients listed for HT.The FELICITAR registry (Frailty Evaluation after List Inclusion, Characteristics and Influence on TrAnsplantation And Results) a prospective that includes HT three centers, from January 2017 April 2019. We assessed presence frailty, depression, cognitive impairment, quality life when included.Ninety-nine were included. Of this group, 30.6% frail, 55 (56.1%) had...
Combined pre-and post-capillary hypertension (CpcPH) is a relatively common complication of heart failure (HF) associated with poor prognosis. Currently, there no specific therapy approved for this entity. Recently, treatment beta-3 adrenergic receptor (β3AR) agonists was able to improve pulmonary hemodynamics and right ventricular (RV) performance in translational, large animal model chronic PH. The authors present the design phase II randomized clinical trial that tests benefits mirabegron...
Abstract Aims The outpatient diuretic dose is a marker of resistance and prognosis in chronic heart failure (HF). Still, the impact preadmission on efficiency (DE) acute HF not fully known. Methods results We conducted an observational prospective study. All patients admitted for treated with intravenous at least one criterion congestion admission were evaluated. Decongestion [physical examination, hemoconcentration, N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) change, lung...
Introduction Galectin-3 (Gal-3) is an inflammatory marker associated with the development and progression of heart failure (HF). A close relationship between Gal-3 levels renal function has been observed, but data on their interaction in patients acute HF (AHF) are scarce. We aim to assess prognostic during AHF episode. Materials Methods This observational, prospective, multicenter registry hospitalized for AHF. Patients were divided into two groups according estimated glomerular filtration...
Abstract Background and Methods Heart transplant recipients (HTr) have a higher probability of suffer from severe coronavirus disease‐2019 (COVID‐19) in comparison to general population, but their risk has changed over the course pandemic relation various factors. We conducted prospective study including all HTr at COVID‐19 tertiary center between February 2020 October 2022. The aim was analyze how prognosis (incidence pneumonia mortality) evolved time, contextualizing variants, vaccination,...